Recursion to Present at Two Key Healthcare Investor Conferences
Event summary
- Recursion Pharmaceuticals (NASDAQ: RXRX) will present at the 25th Annual Needham Virtual Healthcare Conference on April 13, 2026.
- The company will also participate in the Bank of America Health Care Conference 2026 on May 12, 2026.
- Webcasts will be available on the Recursion Investor Relations website.
- Recursion focuses on AI-driven drug discovery across oncology, rare diseases, neuroscience, and immunology.
The big picture
Recursion's participation in these high-profile investor conferences underscores the growing importance of AI in biotech. As the company continues to decode biology through its Recursion OS platform, its ability to attract investment and partnerships will be critical in advancing its pipeline of differentiated medicines. The biotech sector is increasingly focused on scalable, data-driven approaches to drug discovery, making Recursion a key player to watch.
What we're watching
- Conference Impact
- How Recursion's presentations will influence investor sentiment and stock performance.
- Pipeline Updates
- Whether the company will provide new insights into its clinical-stage pipeline during these conferences.
- AI Integration
- The pace at which Recursion can scale its AI-driven drug discovery platform to deliver tangible results.
Related topics